Johnson & Johnson reported first-quarter results on Tuesday that exceeded Wall Street expectations and raised its full-year forecast, driven by strong demand for key treatments including Darzalex and Tremfya, which helped offset a sharp decline in sales of its blockbuster autoimmune drug Stelara.

PayPal on Tuesday issued a weaker-than-expected profit outlook for 2026 and reported fourth-quarter earnings that missed Wall Street estimates, while announcing a leadership change with Enrique Lores set to become its new president and chief executive officer.

Shares of Pfizer edged lower in premarket trading on Tuesday, even after the drugmaker reported fourth-quarter earnings and revenue that exceeded Wall Street expectations.

The Walt Disney Company delivered stronger-than-expected earnings for its fiscal third quarter, driven by gains in streaming and increased spending at U.S. theme parks, prompting the entertainment giant to raise its full-year earnings outlook.

CrowdStrike Holdings Inc. saw its stock fall in early trading on Wednesday after the cybersecurity firm issued a lower-than-expected earnings forecast for the fiscal fourth quarter.